Accelerator Corporation

Accelerator Corporation, founded in 2003, was a privately-held biotechnology investment and management firm with operations in Seattle, WA and New York City. The company served as a life science investment vehicle supporting emerging biotechnology research by providing capital, laboratory space, and operational expertise to early-stage biotech startups — with a particular focus on the New York City life sciences ecosystem. In December 2017, Accelerator Corporation announced a name change to Accelerator Life Science Partners, reflecting its commitment to developing long-term partnerships with portfolio companies; investors included AbbVie, Pfizer Venture Investments, Johnson & Johnson Innovation – JJDC, ARCH Venture Partners, Eli Lilly, and Alexandria Venture Investments.